These events are enforced by BCR-ABL1 itself, or by other kinases (e.g., JAK2); all of these mechanisms are underpinned by PP2A activity suppression in CP and BP-CML primary progenitor cells [96]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.